Trials / Completed
CompletedNCT01533298
A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition
A Randomized, Open, Multicenter, Compared Phase III Trial to Evaluate the Safety, Efficacy of CombiflexOmega Peri and SmofKabiven Peripheral in Postoperative Patients Requiring Parenteral Nutrition
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- JW Life Science · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of CombiflexOmega peri in comparison to SmofKabiven peripheral in postoperative patients requiring parenteral nutrition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CombiflexOmega peri | intravenously over 3 days infusion |
| DRUG | SmofKabiven peripheral | intravenously over 3 days infusion |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-12-01
- Completion
- 2012-01-01
- First posted
- 2012-02-15
- Last updated
- 2013-02-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01533298. Inclusion in this directory is not an endorsement.